Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BioHealx | Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BioHealx | Device | Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening, preventing reinfection, while allowing for drainage through the external opening during healing. |
| Measure | Description | Time Frame |
|---|---|---|
| Successful Closure Repair | Successful closure repair of the anal fistula as determined by complete healing, i.e., internal and external opening closed (no evidence of an external opening present) without drainage | 12 Months |
| Non-Recurrence Incidence | Non-recurrence incidence determined by continued closure of the external fistula opening. | 24 and 36 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal Incontinence Quality of Life | Fecal incontinence Quality of Life (FIQL) score at each follow-up visit (baseline visit and from 6-month and at subsequent follow-up visit) The FIQL score includes 29 items which form four scales: lifestyle, coping/behavior, depression/self-perception, and embarrassment. The FIQL scale range includes a range of response options across its items, from 1 to 4 for most items, 1 to 5 for one item, and 1 to 6 for another. Lower scores indicate lower quality of life. |
| Measure | Description | Time Frame |
|---|---|---|
| Device and Procedure Related Adverse Events | Measurement of device and/or procedure related adverse events will be recorded. | 6 Weeks, 3 Months, 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Adverse Event Comparison |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients presenting for treatment of mature, cryptogenic, transsphincteric, non-branching fistulas in ano via tissue apposition.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Katy Feeny | Contact | 610-860-6577 | kjclinconsulting@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Colorectal Institute | Recruiting | Fort Myers | Florida | 33912 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012003 | Rectal Fistula |
| ID | Term |
|---|---|
| D007412 | Intestinal Fistula |
| D016154 | Digestive System Fistula |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Fecal Incontinence Severity Index (FISI) | Fecal Incontinence Severity Index (FISI) at each follow-up visit (baseline visit and from 6-month and at each subsequent follow-up visit). The Fecal Incontinence Severity Index (FISI) Scale typically ranges from 0 to a maximum value 61. Higher scores on the FISI scale indicate a worse outcome, reflecting greater severity of fecal incontinence symptoms. | 6 Month, 9 Month, 12 Month, 24 Month, 36 Month |
| Health Related Quality of Life | SF-36 Quality of life data will be collected (baseline visit and from 6-month and at each subsequent follow-up visit). Short Form 36 (SF-36) is a generic self-reported outcome measure that quantifies the quality of life in relation to health status. It is a 36-item valid and reliable evaluation with eight areas covering physical functioning, role limitations brought on by physical issues, bodily pain, general health perceptions, vitality, social functioning, role limitations brought on by emotional issues, and perceived mental health. The SF-36 also contains a single question called "health transition" that measures how respondents feel their over health status has changed over the course of a year. The scores range from 0-100 (the worst possible to the most possible) | 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Pain Score | Wong-Baker FACES Pain scores will be recorded at each follow-up visit (baseline visit and from 6-month and at each subsequent follow-up visit). The FACES Pain Scale ranges from 0 (no pain) to 10 (the worst pain). | 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Rescue Analgesic and Therapeutic Antibiotic Use | Occurrence of use of rescue analgesic and/or therapeutic antibiotics beyond post-operative Day 5 after the surgery and at each follow-up visit. | 6 Weeks, 3 Months, 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
Measurement of, incidence, severity and persistence of device and/or procedure related adverse events will be recorded and compared with previous BioHealx Anal Fistula Device clinical results and relevant comparator devices (e.g. cutting seton) and procedures (e.g., LIFT).
| 6 Weeks, 3 Months, 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Occurrence of Fecal Incontinence | Fecal continence will be measured through combination of the patient reported Fecal Incontinence Quality of Life questionnaire (FIQL) and the Fecal Incontinence Severity Index questionnaire (FISI) scores at baseline and subsequent periods. Fecal incontinence Quality of Life (FIQL) score at each follow-up visit (baseline visit and from 6-month and at subsequent follow-up visit) The FIQL score includes 29 items which form four scales: lifestyle, coping/behavior, depression/self-perception, and embarrassment. The FIQL scale range includes a range of response options across its items, from 1 to 4 for most items, 1 to 5 for one item, and 1 to 6 for another. Lower scores indicate lower quality of life. The Fecal Incontinence Severity Index (FISI) Scale typically ranges from 0 to a maximum value 61. Higher scores on the FISI scale indicate a worse outcome, reflecting greater severity of fecal incontinence symptoms. | Baseline, 6 Weeks, 3 Months, 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Rescue Analgesic and Therapeutic Antibiotic Comparison | Rescue analgesic and therapeutic antibiotic use will be recorded and compared with previous BioHealx Anal Fistula Device clinical results and other relevant fistula treatments. | 6 Weeks, 3 Months, 6 Months, 9 Months, 12 Months, 24 Months, 36 Months |
| Hackensack University Medical Center | Recruiting | Hackensack | New Jersey | 07601 | United States |
|
| Weill Cornell Medicine | Recruiting | New York | New York | 10021 | United States |
|
| Northwell Health | Recruiting | Staten Island | New York | 10305 | United States |
|
| Maininle Health Lankenau | Recruiting | Bryn Mawr | Pennsylvania | 19010 | United States |
|
| Geisinger | Recruiting | Danville | Pennsylvania | 17822 | United States |
|
| D005767 | Gastrointestinal Diseases |
| D012002 | Rectal Diseases |
| D005402 | Fistula |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |